Auxly Cannabis Group (XLY) AI Stock Analysis

• Market Cap: C$186.94M
• Dividend Yield: N/A
• Average Volume (3M): 1.16M
• Price to Earnings (P/E): 8.3
• Beta (1Y): 2.70
• Revenue Growth: 26.78%
• EPS Growth: N/A
• Country: CA
• Employees: 388
• Sector: Healthcare
• Sector Strength: 38
• Industry: Drug Manufacturers - Specialty & Generic
• EPS (TTM): <0.01
• Shares Outstanding: 1,335,289,000
• 10 Day Avg. Volume: 522,450
• 30 Day Avg. Volume: 1,156,103
• PEG Ratio: N/A
• Price to Book (P/B): 0.00
• Price to Sales (P/S): 0.00
• P/FCF Ratio: 0.00
• Enterprise Value/Market Cap: N/A
• Enterprise Value/Revenue: N/A
• Enterprise Value/Gross Profit: N/A
• Enterprise Value/Ebitda: N/A
• 1Y Price Target: N/A
• Price Target Upside: N/A
• Rating Consensus: Hold
• Number of Analyst Covering: 0

• Rating: 68 Neutral
• Price Target: C$0.00 ▼(-100.00% Downside)

Auxly Cannabis Group's stock score is driven by strong technical indicators and a favorable valuation, reflecting positive market momentum and potential undervaluation. Financial performance shows improvement, but ongoing net losses and lack of profitability are concerns. Corporate events highlight improved financial stability, though the absence of earnings calls may affect transparency.

Auxly Cannabis Group Business Overview & Revenue Model

Company Description

Auxly Cannabis Group Inc. (XLY) is a Canadian company operating in the cannabis sector, focusing on the development, manufacturing, and distribution of cannabis products. Established to provide consumers with a diverse portfolio of cannabis products, Auxly's offerings include dried cannabis, cannabis oils, and derivative products such as edibles and vapes. The company positions itself as an innovator in the cannabis industry, leveraging strategic partnerships and a vertically integrated approach to enhance its market presence and product quality.

How the Company Makes Money

Auxly Cannabis Group generates revenue primarily through the cultivation, production, and sale of cannabis products. The company's revenue model is built around its vertically integrated operations, which include cultivation facilities, processing and manufacturing plants, and a distribution network that enables it to bring a variety of branded cannabis products to market. Key revenue streams include the sale of recreational and medical cannabis products across Canada, as well as international markets where cannabis is legal. Auxly also capitalizes on strategic partnerships with other cannabis companies and retailers to expand its distribution reach and enhance product offerings. Additionally, the company invests in research and development to create innovative products, which helps to maintain competitive pricing and attract diverse consumer segments.

Auxly Cannabis Group Financial Statement Overview

Summary

Auxly Cannabis Group is making strides towards financial improvement, with notable revenue growth and stronger cash flow positions. Despite ongoing net losses, the company shows signs of better operational efficiency and leverage management. Continued focus on profitability and debt management will be crucial for sustained financial health.

Income Statement

Auxly Cannabis Group has shown a positive revenue growth trend, with a recent increase from $101 million in 2023 to $122 million in 2024. However, despite improved gross profit margins, the company is still experiencing net losses, which affects the net profit margin negatively. The EBITDA margin has turned positive, indicating some operational improvements, but the absence of EBIT margin due to zero EBIT is a concern.

Balance Sheet

The company has improved its equity position, with shareholder equity increasing significantly from 2023 to 2024. The debt-to-equity ratio has improved as well, indicating better leverage management. However, the equity ratio shows room for improvement, reflecting moderate financial stability amidst high total liabilities.

Cash Flow

Auxly Cannabis Group has exhibited strong free cash flow growth, with free cash flow growing from $6.61 million in 2023 to $14.02 million in 2024. The operating cash flow to net income ratio is positive, showing that the company is generating cash from operations despite net losses. The improvement in free cash flow to net income ratio reflects better cash flow management.

Breakdown	Dec 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020
Income Statement
Total Revenue	122.33M	101.08M	94.47M	83.83M	50.80M
Gross Profit	59.93M	21.28M	17.92M	19.29M	11.14M
EBITDA	24.38M	-10.82M	-93.40M	-13.64M	-57.18M
Net Income	-16.35M	-44.51M	-130.29M	-45.91M	-87.43M
Balance Sheet
Total Assets	261.53M	261.90M	331.82M	450.42M	378.96M
Cash, Cash Equivalents and Short-Term Investments	18.50M	15.75M	14.78M	14.89M	21.50M
Total Debt	68.47M	159.04M	193.59M	190.10M	124.68M
Total Liabilities	145.87M	210.86M	246.13M	242.31M	187.43M
Stockholders Equity	115.66M	51.05M	90.41M	212.52M	195.94M
Cash Flow
Free Cash Flow	14.02M	6.61M	-11.67M	-50.01M	-53.86M
Operating Cash Flow	16.78M	8.21M	-2.48M	-49.63M	-33.13M
Investing Cash Flow	-445.00K	-1.56M	1.18M	17.33M	-14.53M
Financing Cash Flow	-13.59M	-5.68M	1.18M	26.40M	24.74M

Auxly Cannabis Group Technical Analysis

• Technical Analysis Sentiment: Positive
• Last Price: 0.14
• 50DMA: Positive
• 100DMA: Positive
• 200DMA: Positive
• MACD: Positive
• RSI: Neutral
• STOCH: Positive

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For TSE:XLY, the sentiment is Positive. The current price of 0.14 is below the 20-day moving average (MA) of 0.14, above the 50-day MA of 0.11, and above the 200-day MA of 0.07, indicating a neutral trend. The MACD of <0.01 indicates Positive momentum. The RSI at 55.90 is Neutral, neither overbought nor oversold. The STOCH value of 16.67 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for TSE:XLY.

Auxly Cannabis Group Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
XLY	68 Neutral	C$186.94M	8.33	18.60%	―	26.78%	―
Sector *	60 Neutral	HK$17.54B	4.97	-4.95%	3.61%	9.71%	-38.85%
OGI	―	$183.70M	20.29	4.76%	―	―	―
MEDIF	―	$21.44M	―	-16.22%	―	―	―
DBCCF	―	$35.68M	3.75	20.78%	―	―	―
HLS	56 Neutral	C$157.42M	―	-23.05%	―	-3.73%	32.70%
MILFF	―	$23.14M	16.45	6.23%	―	―	―

Auxly Cannabis Group Corporate Events

Auxly Cannabis Group to Release Q2 2025 Financial Results

Auxly Cannabis Group Inc. announced it will release its second quarter and six-month financial results for 2025 on August 14, 2025. Notably, the company will not conduct an earnings conference call and does not plan to reinstate such calls until further notice, which may impact investor engagement and transparency.

Auxly Cannabis Group Strengthens Financial Position with Key Debt Reduction Transactions

Auxly Cannabis Group has successfully completed two significant financial transactions, including amending its credit facility with the Bank of Montreal and settling its debts with Imperial Brands. These moves have eliminated $21 million in debt, reduced annual debt service obligations by $700,000, and provided access to a new $10 million revolving facility, enhancing the company’s financial stability and growth potential.

Auxly Cannabis Group Announces Successful Shareholder Meeting Results

Auxly Cannabis Group Inc. announced the results of its annual general meeting of shareholders, where all proposed matters were approved by the requisite majority. The meeting saw the election of directors and the re-appointment of Ernst & Young LLP as auditors, reflecting strong shareholder support and stability in the company’s governance.

Auxly Cannabis Group Strengthens Financial Position with Key Agreements

Auxly Cannabis Group Inc. has announced two significant agreements aimed at strengthening its financial position. The company has entered into a non-binding agreement to amend its existing credit facility with the Bank of Montreal, which will enhance liquidity and provide flexibility for growth initiatives. Additionally, Auxly has reached an exchange agreement with Imperial Brands to settle over $21 million of debt through equity instruments, thereby improving its capital structure and financial stability.

Auxly Cannabis Group Schedules Annual General Meeting for June 2025

Auxly Cannabis Group Inc. announced its Annual General Meeting of Shareholders will be held on June 30, 2025, in Toronto. Due to limited seating, shareholders must pre-register to attend in person, and an audio teleconference will be available for real-time listening, though voting must be done in advance.

Auxly Cannabis Group Reports Strong Q1 2025 Results with Significant Revenue Growth

Auxly Cannabis Group Inc. reported a strong financial performance for the first quarter of 2025, with a 29% increase in net revenues to $32.7 million and a 232% rise in adjusted EBITDA. The company maintained its position as a top player in the Canadian cannabis market, with its Back Forty brand achieving the number one spot in Canada. Auxly’s strategic focus on innovation and operational efficiency has resulted in significant growth, reinforcing its market leadership and setting a solid foundation for future expansion.

The most recent analyst rating on (IMAX) stock is a Hold with a $20.00 price target. To see the full list of analyst forecasts on IMAX stock, see the IMAX Stock Forecast page.